Loading...
Present and future of metastatic colorectal cancer treatment: A review of new candidate targets
In the last two decades, great efforts have been made in the treatment of metastatic colorectal cancer (mCRC) due to the approval of new target agents for cytotoxic drugs. Unfortunately, a large percentage of patients present with metastasis at the time of diagnosis or relapse after a few months. Th...
Saved in:
Published in: | World J Gastroenterol |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Baishideng Publishing Group Inc
2017
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5514633/ https://ncbi.nlm.nih.gov/pubmed/28765689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v23.i26.4675 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|